Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Taiwan · Delayed Price · Currency is TWD

126.50

+2.00 (1.61%)

Nov 6, 2026, 1:30 PM CST

Market Cap	10.72B -9.6%
Revenue (ttm)	4.27B +0.2%
Net Income	1.14B +28.9%
EPS	13.46 +28.9%
Shares Out	84.72M
PE Ratio	9.40
Forward PE	9.13
Dividend	7.75 (6.13%)
Ex-Dividend Date	Mar 26, 2026

Volume	413,218
Open	121.50
Previous Close	124.50
Day's Range	115.50 - 126.50
52-Week Range	118.00 - 161.00
Beta	0.37
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides adminis... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1992

Employees 401

Stock Exchange Taipei Exchange

Ticker Symbol 3218

Full Company Profile

Financial Performance

In 2025, TPEX:3218's revenue was 4.20 billion, a decrease of -0.57% compared to the previous year's 4.23 billion. Earnings were 1.04 billion, a decrease of -2.07%.

Financial Statements